Infection Control Market: Growing Healthcare Awareness among the Population and Poor Sanitation Conditions in Underdeveloped Countries Expected to Boost the Market

The various types of treatment options that are commercially available in the market for cancer include traditional surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, photodynamic therapy, stem cell transplant therapy, etc. Among these above-mentioned treatment options, the patients who are receiving chemotherapy are more prone to get infections through their daily activities. One out of every 10 patients who are treated with chemotherapy gets an infection, which needs a hospital visit.

Microbes or microorganisms that enter into body of a cancer patient usually acquire these infections and results in illness. The main type of microorganisms causing these infections includes viruses, bacteria, protozoa and some fungal organisms. The infections that are developed in cancer patients can be more harmful than those infections developed in healthy individuals.

Obtain Report Details @ http://www.transparencymarketresearch.com/infection-control-market.html

According to the Centers for Disease Control and Prevention (CDC), it was estimated that approximately 1.5 million new cases of cancer patients were diagnosed in the United States in year 2010. With improvements in cancer treatment therapies and number of geriatric population in the U.S., the total number of cancer patients is expect to increase in coming years. Even though there is various advancements oncology treatment, infections associated with these therapies remain a major cause of mortality and morbidity in cancer patients. Several factors those are responsible to developing infections in cancer patients including immunosuppresion from their primary cancer and drug therapy treatment.

As cancer patients often require the placement of intravascular devices as implanted ports to provide ease with drug therapy infusion for linger period, there is chance of direct portal entry of microorganisms in to the patient body. Thus, proper cancer prevention practices are essential to minimize the risks and complications associated with various cancer treatment therapies. Some of the standard precautions to control the infections associated with cancer therapy include usage of personal protective equipments, hand hygiene procedures, injection safety, proper medication storage and cleaning devices.

The infection control market in cancer therapy is expected to have a huge growth potential in next few years. The contributing factors behind such an assessment include rise in base of geriatric population, increasing number of cancer patients globally and advancements in cancer treatment technologies. Additionally, growing healthcare awareness among the population and poor sanitation conditions in underdeveloped countries further expected to boost the market.

For more information on this report, fill the form @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7832

Geographically, North America accounts for the largest share of the infection control market in cancer therapy followed by the European region. The dominance of North America in this market is seen due to rapidly aging population, which can afford high cost cancer treatment and presence of various market leaders that allows easy penetration in the North America region.

European infection control market in cancer therapy follows the North America market due to extensive promotion and funding for cancer treatment by the European government such as Germany and the U.K. Asia-Pacific region is expected to witness fastest growth rate in the near future due to rising population base and increasing awareness about the cancer treatment.

Some of the major players operating in this market includes 3M Healthcare Company, Advanced Sterilization Products Services, Inc, Nordion, Inc., Steris Corporation, Synergy Health, Plc, Getinge Group, Ahlstrom Corporation, Honeywell International, Inc., Sakura Global Holding Company, Kimberly Clark Corporation, Cisa S.P.A., Sterigenics International, Inc. and others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.